{"id":66959,"date":"2026-06-09T03:03:08","date_gmt":"2026-06-09T03:03:08","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/66959\/"},"modified":"2026-06-09T03:03:08","modified_gmt":"2026-06-09T03:03:08","slug":"ai-reimagines-caffeine-as-a-molecular-off-switch-for-engineered-cells","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/66959\/","title":{"rendered":"AI Reimagines Caffeine as a Molecular Off\u2011Switch for Engineered Cells"},"content":{"rendered":"

\"coffee<\/a>Credit: asikkk \/ iStock \/ Getty Images Plus<\/p>\n

A cup of coffee can mean many things: a daily part of our routine, a moment of calm, a midday boost. But zoom in past the steam, past the roasted aromatics, down to the caffeine molecule itself, and a different story emerges. At the Texas A&M Health Institute of Biosciences and Technology, researchers have turned this everyday stimulant into something far more unexpected: a molecular \u201cpause button\u201d for engineered cells.<\/p>\n

In a study published in the Journal of the American Chemical Society (JACS), the team unveiled CODS, a caffeine\u2011operated dissociation system built using AI<\/a>\u2011guided de novo protein design. The paper, \u201cAI\u2011Guided De Novo Design of a Caffeine\u2011Induced Protein Dissociation System<\/a>,\u201d describes how the group reprogrammed \u201can existing caffeine-responsive chemically induced proximity (CIP) module into a ligand-dependent dissociation system.\u201d<\/p>\n

\u201cAI is changing how we design biology,\u201d said senior author Yubin Zhou, MD, PhD. \u201cInstead of relying only on protein parts that already exist in nature, we can now design new mini proteins with specific behaviors. Here, we used AI to help turn caffeine into a precise trigger for controlling engineered cells.\u201d<\/p>\n

\"caffeineA team of Texas A&M Health researchers led by Yubin Zhou, MD, PhD, is using caffeine to precisely control engineered cells, a step toward safer and more responsive therapies. [Texas A&M University]The CODS system pairs a caffeine\u2011binding protein with a synthetic mini\u2011binder designed using the BindCraft platform. In the absence of caffeine, the two components stay locked together. Add caffeine, and the complex snaps apart, releasing the binder and shutting down the attached cellular function. As Tianlu Wang, PhD, a postdoctoral fellow in the Zhou lab, put it, \u201cMany genetically-encoded molecular tools act like accelerators. CODS gives us something closer to a brake or pause button.\u201d<\/p>\n

The team demonstrated CODS across several biological contexts. In engineered gene circuits, caffeine addition sharply reduced transcriptional activity. In a rewired pyroptosis pathway, caffeine triggered inflammatory cell death by freeing the active domain of gasdermin D. And in perhaps the most translational example, CODS served as a conditional deactivator for CAR T cells, temporarily dampening their activity without destroying the therapeutic cells.<\/p>\n

\u201cPowerful therapies need powerful control,\u201d Zhou said. \u201cBy combining AI\u2011designed proteins, high\u2011performance computing, and familiar small molecules, we are building a new language for communicating with engineered cells.\u201d<\/p>\n

The design process itself leaned heavily on computation. Graduate student Brendan McKee led the AI\u2011guided binder design and molecular modeling, while Tatsuki Nonomura spearheaded the molecular engineering and live\u2011cell validation. The Texas A&M High Performance Research Computing service provided the infrastructure needed to run large\u2011scale simulations. \u201cHigh\u2011performance computing was essential for this project,\u201d Zhou noted. \u201cIt helped us move from a conceptual idea to a functional molecular switch much faster.\u201d<\/p>\n

Although caffeine is not a therapeutic molecule, its safety and familiarity make it an appealing control signal. As Zhou emphasized, \u201cCoffee will not replace medicine. But caffeine can help us imagine medicines that are more controllable, more responsive, and safer for patients.\u201d The researchers\u2019 next steps include further testing in therapeutic cells, animal models, and disease-relevant settings before moving toward clinical use.<\/p>\n

CODS now joins a growing toolkit of AI\u2011designed molecular switches, offering a blueprint for future systems responsive to other safe, accessible molecules. As programmable cell therapies advance, the ability to modulate them with something as simple as caffeine may prove unexpectedly powerful.<\/p>\n

The authors report that a patent application covering the CODS platform has been filed by Texas A&M University, with Y.Z., T.N., B.M., and T.W. listed as inventors (U.S. Provisional Patent Application No. 64\/022,078).<\/p>\n","protected":false},"excerpt":{"rendered":"Credit: asikkk \/ iStock \/ Getty Images Plus A cup of coffee can mean many things: a daily…\n","protected":false},"author":2,"featured_media":66960,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,37689,25,37691,66,4082,37690,4792,37688],"class_list":["post-66959","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ai","tag-ai","tag-animal-models","tag-artificial-intelligence","tag-cods","tag-news","tag-proteins","tag-t-cells","tag-topics","tag-translational-medicine"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/66959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=66959"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/66959\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/66960"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=66959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=66959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=66959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}